ANI gets FDA OK for generic MycobutinRifabutin capsules have a market value of approximately $16.6 million, according to IQVIA. Camber launches generic Northera in 2 new dosage strengthsCamber's droxidopa capsules are now available in 100 mg, 200 mg and 300 mg strengths. FDA approves Novadoz Pharmaceuticals' generic Gabitril, MSN's manufacturing facility FDA gives Novadoz permission for generic Gabitril, as well as for MSN’s new state-of-the-art manufacturing facility. Aurobindo gets FDA OK for generic Bystolic Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA. Eagle receives FDA approval for generic Vasostrict Vasostrict had a market value of $786 million in 2020. Teva intros 2 generics Teva is offering generic Duexis and generic Daraprim. Natco enters agreement to acquire Dash Pharmaceuticals The acquisition of Dash Pharmaceuticals will provide additional opportunities in the United States, the company said. Sun Pharma receives FDA permission for generic AmBisome Liposome injection AmBisome Liposome for injection had a market value of approximately $136 million as of October 2021. Dr. Reddy’s obtains FDA OK for generic Nuvaring Dr. Reddy’s has received the Food and Drug Administration’s stamp of approval for VeraRing, a generic of Merck’s Nuvaring. Zydus Cadila’s generic Cariprazine obtains tentative FDA approval Cariprazine is an atypical antipsychotic medication used for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar disorder. First Previous 96 97 98 99 100 Next Last
